June 24, 2025

Press Release: Official BRACELET-1 trial results indicate that adding the oncolytic virus immunotherapy pelareorep to paclitaxel chemotherapy warrants further investigation in HR+ HER2- metastatic breast cancer

April 4, 2024

The Spring 2024 advocacy blog Considering Clinical Trials is now available

March 7, 2024

The March 2024 News from ECOG-ACRIN blog is now available

February 16, 2024

EA5221 / ACHIEVE Educational Materials

February 15, 2024

EA5221 / ACHIEVE Home Page

October 10, 2023

The Fall 2023 advocacy blog Considering Clinical Trials is now available

February 1, 2023

Ongoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer

September 8, 2022

Press Release: ECOG-ACRIN completes the first randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

June 4, 2022

E3311: No differences in survival outcomes based on tobacco history in HPV-associated head and neck cancer

ECOG-ACRIN Cancer Research Group